F. Sarici And S. Aksoy, "Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2, pp.85-91, 2021
Sarici, F. And Aksoy, S. 2021. Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2 , 85-91.
Sarici, F., & Aksoy, S., (2021). Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2, 85-91.
Sarici, Furkan, And Serean Aksoy. "Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2, 85-91, 2021
Sarici, Furkan And Aksoy, Serean. "Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2, pp.85-91, 2021
Sarici, F. And Aksoy, S. (2021) . "Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.2, pp.85-91.
@article{article, author={Furkan Sarici And author={Serean Aksoy}, title={Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2021, pages={85-91} }